Nuance Communications is expanding the scope of its strategic partnership with athenahealth. The latter will specifically be integrating Nuance’s cloud-based Dragon Medical voice solution into its own mobile app and athenaOne Electronic Health Records (EHR) solution.
In doing so, athenahealth is hoping to reduce the administrative burden on healthcare professionals. The improved, Nuance-powered athenaOne Dictation feature will allow doctors to use their voices to take notes during an appointment. As a result, they will not need to fill in as much paperwork afterward, and will still be able to devote their full attention to the patient during the session itself.
The two companies will eventually supplement those Dictation capabilities with the release of a full voice assistant sometime later in 2021. The voice assistant is currently in the beta phase, while athenaOne Dictation is available today.
The athenaOne platform offers support for 110 different medical specialties, and enables back-end management and patient engagement in addition to basic record keeping. The solution is compatible with other clinical applications, including reporting and telehealth applications.
“The athenaOne Mobile App has helped me capture my patients’ stories much more thoroughly and my assessments now reflect more complex thinking and differential diagnoses,” said Valley View Hospital Family Medicine Specialist Angela Ammon. “The accuracy of the solution is better than the other voice recognition programs I have used in the past. It’s easy to train the names of local physicians and is excellent for recognizing medication names and medical terms.”
“When we reduce documentation burden with conversational AI technology, clinicians can give more time and personalized care to their patients,” added Nuance Chief Strategy Officer Peter Durlach. “We are helping clinicians document patient encounters easily and consistently across mobile and desktop devices.”
Nuance has spent much of the past year working to extend the reach of its Dragon Medical platform. The company has also partnered with MITRE in an effort to provide cancer researchers with better data for their studies.